Safe inclusion of the entire pancreas as a component of the multivisceral graft

Transplantation

Volumn 86, Issue 1, 2008, Pages 114-116

  Vianna, Rodrigo ^a   Fridell, Jonathan A ^a   Mangus, Richard ^a   Hollinger, Edward F ^a   Matiosky, Alysson ^a   Tector, A Joseph ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Multivisceral transplantation; Pancreas transplantation

Indexed keywords

AMYLASE; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; TRIACYLGLYCEROL LIPASE; ANTIDIABETIC AGENT; INSULIN; PNLIP PROTEIN, HUMAN;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AMYLASE BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; ENZYME ASSAY; FATALITY; FEMALE; GLYCEMIC CONTROL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERALIMENTATION; INTESTINE GRAFT; LIVER PRESERVATION; MALE; MULTIVISCERAL GRAFT; ORGAN TRANSPLANTATION; PANCREAS BIOPSY; PANCREAS TRANSPLANTATION; PANCREATITIS; PATIENT SAFETY; PNEUMOCYSTOSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; RETRANSPLANTATION; SCHOOL CHILD; SURVIVAL RATE; TREATMENT RESPONSE; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; BLOOD; INFANT; INTESTINE; MIDDLE AGED; REOPERATION; TIME; TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AMYLASES; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INSULIN; INTESTINES; LIPASE; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; REOPERATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 49849094510     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318177df76     Document Type: Article

References (13)

1. Tzakis AG, Kato T, Levi DM, et al. 100 multivisceral transplants at a single center. Ann Surg 2005; 242: 480.
2. Nishida S, Kato T, Levi D, et al. Intestinal transplantation for trauma patients. Transplant Proc 2002; 34: 913.
3. Vianna R, Giovanardi RO, Fridell JA, et al. Multivisceral transplantation for diffuse portomesenteric thrombosis in a patient with life-threatening esophagogastroduodenal bleeding. Transplantation 2005; 27 80: 534.
4. GrantD, WallW,Mimeault R,et al. Successful small-bowel/liver transplantation. Lancet 27 1990; 335: 181.
5. Sudan DL, Iyer KR, Deroover A, et al. A new technique for combined liver/small intestinal transplantation. Transplantation 2001; 72: 1846.
6. Starzl TE, Todo S, Tzakis A, et al. The many faces of multivisceral transplantation. Surg Gynecol Obstet 1991; 172: 335.
7. Bueno J, Abu-Elmagd K, Mazariegos G, et al. Composite liver-small bowel allografts with preservation of donor duodenum and hepatic biliary system in children. J Pediatr Surg 2000; 35: 291.
8. Takahashi H, Delacruz V, Sarwar S, et al. Contemporaneous chronic rejection of multiple allografts with principal pancreatic involvement in modified multivisceral transplantation. Pediatr Transplant 2007; 11: 448.
9. Grant D. Intestinal Transplant Registry. 2007.
10. Fridell JA, Mazariegos GV, OrensteinD,etal. Liver and intestinal transplantation in a child with cystic fibrosis: A case report. Pediatr Transplant 2003; 7: 240.
11. FishbeinT, FlormanS,GondolesiG,et al. Noncomposite simultaneous liver and intestinal transplantation. Transplantation 2003; 75: 564.
12. Agarwal A, Murdock P, Pescovitz MD, et al. Follow-up experience using histidine-tryptophan ketoglutarate solution in clinical pancreas transplantation. Transplant Proc 2005; 37: 3523.
13. Fridell JA, Agarwal A, Milgrom ML, et al. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution for organ preservation in clinical pancreas transplantation. Transplantation 2004; 77: 1304.